L01XE Protein kinase inhibitors

PheWeb

RX_L01XE

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Medicine purchases: ATC L01XE

1538

Check pre-conditions, main-only, mode, ICD version None

1217

Check minimum number of events

Min. number of events 3

1217

Include endpoints None

1217

RX_L01XE

Extra metadata

First used in FinnGen datafreeze DF3

Similar endpoints

↥

List of similar endpoints to L01XE Protein kinase inhibitors based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

ILD medications: nintendanib

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	1174	607	567
Unadjusted prevalence (%)	0.38	0.35	0.42
Mean age at first event (years)	65.22	63.51	67.05

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_L01XE – L01XE Protein kinase inhibitors
GWS hits:

Survival analyses between endpoints

↥

Plot

before L01XE Protein kinase inhibitors
after L01XE Protein kinase inhibitors

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after L01XE Protein kinase inhibitors

↥